Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Name: Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
License: Public Domain

Seattle Children's Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

solid tumor (excluding cns), liver cell carcinoma, malignant rhabdoid tumor, yolk sac tumor, liposarcoma, rhabdomyosarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143563
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.